Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment

Ewing sarcoma (EwS) is a highly aggressive cancer and the second most common malignant bone tumor of children and young adults. Although patients with localized disease have a survival rate of approximately 75%, the prognosis for patients with metastatic disease remains dismal (<30%) and has...

Full description

Bibliographic Details
Main Authors: Manideep C. Pachva, Horton Lai, Andy Jia, Melanie Rouleau, Poul H. Sorensen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.726205/full
_version_ 1818573759555043328
author Manideep C. Pachva
Manideep C. Pachva
Horton Lai
Horton Lai
Andy Jia
Andy Jia
Melanie Rouleau
Melanie Rouleau
Poul H. Sorensen
Poul H. Sorensen
author_facet Manideep C. Pachva
Manideep C. Pachva
Horton Lai
Horton Lai
Andy Jia
Andy Jia
Melanie Rouleau
Melanie Rouleau
Poul H. Sorensen
Poul H. Sorensen
author_sort Manideep C. Pachva
collection DOAJ
description Ewing sarcoma (EwS) is a highly aggressive cancer and the second most common malignant bone tumor of children and young adults. Although patients with localized disease have a survival rate of approximately 75%, the prognosis for patients with metastatic disease remains dismal (<30%) and has not improved in decades. Standard-of-care treatments include local therapies such as surgery and radiotherapy, in addition to poly-agent adjuvant chemotherapy, and are often associated with long-term disability and reduced quality of life. Novel targeted therapeutic strategies that are more efficacious and less toxic are therefore desperately needed, particularly for metastatic disease, given that the presence of metastasis remains the most powerful predictor of poor outcome in EwS. Intercellular communication within the tumor microenvironment is emerging as a crucial mechanism for cancer cells to establish immunosuppressive and cancer-permissive environments, potentially leading to metastasis. Altering this communication within the tumor microenvironment, thereby preventing the transfer of oncogenic signals and molecules, represents a highly promising therapeutic strategy. To achieve this, extracellular vesicles (EVs) offer a candidate mechanism as they are actively released by tumor cells and enriched with proteins and RNAs. EVs are membrane-bound particles released by normal and tumor cells, that play pivotal roles in intercellular communication, including cross-talk between tumor, stromal fibroblast, and immune cells in the local tumor microenvironment and systemic circulation. EwS EVs, including the smaller exosomes and larger microvesicles, have the potential to reprogram a diversity of cells in the tumor microenvironment, by transferring various biomolecules in a cell-specific manner. Insights into the various biomolecules packed in EwS EVs as cargos and the molecular changes they trigger in recipient cells of the tumor microenvironment will shed light on various potential targets for therapeutic intervention in EwS. This review details EwS EVs composition, their potential role in metastasis and in the reprogramming of various cells of the tumor microenvironment, and the potential for clinical intervention.
first_indexed 2024-12-15T00:17:11Z
format Article
id doaj.art-ed72a8a1cae14ec283417b806cd8bd81
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-15T00:17:11Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-ed72a8a1cae14ec283417b806cd8bd812022-12-21T22:42:26ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-09-01910.3389/fcell.2021.726205726205Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor MicroenvironmentManideep C. Pachva0Manideep C. Pachva1Horton Lai2Horton Lai3Andy Jia4Andy Jia5Melanie Rouleau6Melanie Rouleau7Poul H. Sorensen8Poul H. Sorensen9Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, CanadaDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, CanadaDepartment of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, CanadaFaculty of Science, University of British Columbia, Vancouver, BC, CanadaDepartment of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, CanadaFaculty of Science, University of British Columbia, Vancouver, BC, CanadaDepartment of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, CanadaDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, CanadaDepartment of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, CanadaDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, CanadaEwing sarcoma (EwS) is a highly aggressive cancer and the second most common malignant bone tumor of children and young adults. Although patients with localized disease have a survival rate of approximately 75%, the prognosis for patients with metastatic disease remains dismal (<30%) and has not improved in decades. Standard-of-care treatments include local therapies such as surgery and radiotherapy, in addition to poly-agent adjuvant chemotherapy, and are often associated with long-term disability and reduced quality of life. Novel targeted therapeutic strategies that are more efficacious and less toxic are therefore desperately needed, particularly for metastatic disease, given that the presence of metastasis remains the most powerful predictor of poor outcome in EwS. Intercellular communication within the tumor microenvironment is emerging as a crucial mechanism for cancer cells to establish immunosuppressive and cancer-permissive environments, potentially leading to metastasis. Altering this communication within the tumor microenvironment, thereby preventing the transfer of oncogenic signals and molecules, represents a highly promising therapeutic strategy. To achieve this, extracellular vesicles (EVs) offer a candidate mechanism as they are actively released by tumor cells and enriched with proteins and RNAs. EVs are membrane-bound particles released by normal and tumor cells, that play pivotal roles in intercellular communication, including cross-talk between tumor, stromal fibroblast, and immune cells in the local tumor microenvironment and systemic circulation. EwS EVs, including the smaller exosomes and larger microvesicles, have the potential to reprogram a diversity of cells in the tumor microenvironment, by transferring various biomolecules in a cell-specific manner. Insights into the various biomolecules packed in EwS EVs as cargos and the molecular changes they trigger in recipient cells of the tumor microenvironment will shed light on various potential targets for therapeutic intervention in EwS. This review details EwS EVs composition, their potential role in metastasis and in the reprogramming of various cells of the tumor microenvironment, and the potential for clinical intervention.https://www.frontiersin.org/articles/10.3389/fcell.2021.726205/fullEwing sarcomatumor microenvironmentreprogrammingimmunosuppressionmetastasisextracellular vesicles
spellingShingle Manideep C. Pachva
Manideep C. Pachva
Horton Lai
Horton Lai
Andy Jia
Andy Jia
Melanie Rouleau
Melanie Rouleau
Poul H. Sorensen
Poul H. Sorensen
Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
Frontiers in Cell and Developmental Biology
Ewing sarcoma
tumor microenvironment
reprogramming
immunosuppression
metastasis
extracellular vesicles
title Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
title_full Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
title_fullStr Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
title_full_unstemmed Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
title_short Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
title_sort extracellular vesicles in reprogramming of the ewing sarcoma tumor microenvironment
topic Ewing sarcoma
tumor microenvironment
reprogramming
immunosuppression
metastasis
extracellular vesicles
url https://www.frontiersin.org/articles/10.3389/fcell.2021.726205/full
work_keys_str_mv AT manideepcpachva extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT manideepcpachva extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT hortonlai extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT hortonlai extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT andyjia extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT andyjia extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT melanierouleau extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT melanierouleau extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT poulhsorensen extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment
AT poulhsorensen extracellularvesiclesinreprogrammingoftheewingsarcomatumormicroenvironment